Document is current
Any future updates will be listed below
-
Authors
Suminski, Aaron J.
Rajala, Abigail Z.
Birn, Rasmus M.
Mueller, Ellie M.
Malone, Margaret E.
Ness, Jared P.
Filla, Caitlyn
Brunner, Kevin
McMillan, Alan B.
Poore, Samuel O.
Williams, Justin C.
Murali, Dhanabalan
Brzeczkowski, Andrea
Hurley, Samuel A.
Dingle, Aaron M.
Zeng, Weifeng
Lake, Wendell B.
Ludwig, Kip A.
Populin, Luis C. https://orcid.org/0000-0003-3729-7728
-
Funding
Funding for this research was provided by:
Defense Sciences Office, DARPA (N66001-17-2-4010)
Grainger Institute for Engineering, University of Wisconsin-Madison
- License Information
-
More Information
Article History
Received: 21 March 2023
Accepted: 19 April 2023
First Online: 28 April 2023
Declarations
:
: All procedures were approved by the University of Wisconsin Institutional Animal Care and Use Committee (IACUC) and the U.S. Army Medical Research and Development Command Animal Care and Use Review Office and were in accordance with the National Institutes of Health’s <i>Guide for the Care and Use of Laboratory Animals</i>.
: Not Applicable.
: RMB is a consultant for NOUS Inc. ABM is a consultant for and holds stock interests in Weinberg Medical Physics. JCW is a co-founder, scientific board member and has stock interests in NeuroOne Medical Inc, NeuraWorx and the NEL Group, which owns Neuronexus Technologies. JCW is also a consultant and has stock interests in NeuonOff Inc. KAL is a scientific board member and has stock interests in NeuroOne Medical Inc. KAL is also a paid member of the scientific advisory board of Cala Health, Blackfynn, Abbott Neuromodulation, Presidio Medical, and Battelle. KAL also is a paid consultant for CVRx, Galvani, and the Alfred Mann Foundation. KAL is a co-founder of NeuronOff Inc and NeuraWorx. LCP is a consultant for and holds stock interests in NeuraWorx. The remaining authors declare no competing interests.
